Cargando…

COVID-19 in Adults With Hypertrophic Cardiomyopathy

Background: Individuals with cardiovascular disease are considered high risk for severe COVID-19. However, the clinical impact of COVID-19 in patients with hypertrophic cardiomyopathy (HCM) is unknown. The purpose of this study was to describe the clinical course and outcomes of COVID-19 in patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arabadjian, Milla E., Reuter, Maria C., Stepanovic, Alexandra, Sherrid, Mark V., Massera, Daniele
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8630625/ https://www.ncbi.nlm.nih.gov/pubmed/34859067 http://dx.doi.org/10.3389/fcvm.2021.745790

Ejemplares similares

Clinical course and outcomes in adults with co-occurring hypertrophic cardiomyopathy and hypertension: a scoping review protocol
por: Arabadjian, Milla, et al.
Publicado: (2023)

Disease Expression and Outcomes in Black and White Adults With Hypertrophic Cardiomyopathy
por: Arabadjian, Milla E., et al.
Publicado: (2021)

Weight loss in hypertrophic cardiomyopathy: A clinical case series
por: Reuter, Maria C., et al.
Publicado: (2023)

Blacks with Hypertrophic Cardiomyopathy Have Lower Quality of Life and Exercise Capacity Than Whites
por: Arabadjian, Milla E., et al.
Publicado: (2020)

Histopathology of the Mitral Valve Residual Leaflet in Obstructive Hypertrophic Cardiomyopathy
por: Troy, Aaron L., et al.
Publicado: (2023)

Indications for Surgery in Obstructive Hypertrophic Cardiomyopathy
por: Sherrid, Mark V.
Publicado: (2020)

Availability and Utilization of Automated External Defibrillators in New York State Schools
por: Arabadjian, Milla, et al.
Publicado: (2021)

Hypertrophic Cardiomyopathy: From Phenotype and Pathogenesis to Treatment
por: Cheng, Zeyi, et al.
Publicado: (2021)

Precision and genomic medicine for dilated and hypertrophic cardiomyopathy
por: Nomura, Seitaro, et al.
Publicado: (2023)

Anxiety Predicts Poor Prognosis in Patients With Hypertrophic Cardiomyopathy
por: He, Chao-Jie, et al.
Publicado: (2022)

Transcriptional bursts and heterogeneity among cardiomyocytes in hypertrophic cardiomyopathy
por: Burkart, Valentin, et al.
Publicado: (2022)

Cardiovascular Imaging in Pregnancy: Valvulopathy, Hypertrophic Cardiomyopathy, and Aortopathy
por: Ismail, Haneen, et al.
Publicado: (2022)

Electrocardiographic and Echocardiographic Predictors of Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy
por: Mandeş, Leonard, et al.
Publicado: (2022)

Basic science methods for the characterization of variants of uncertain significance in hypertrophic cardiomyopathy
por: Doh, Chang Yoon, et al.
Publicado: (2023)

Non-pharmaceutical Interventions for Hypertrophic Cardiomyopathy: A Mini Review
por: He, Miaomiao, et al.
Publicado: (2021)

Stable Rates of Obstructive Hypertrophic Cardiomyopathy in a Contemporary Era
por: Butzner, Michael, et al.
Publicado: (2022)

Further Considerations in Childhood-Onset Hypertrophic Cardiomyopathy Genetic Testing
por: Monasky, Michelle M., et al.
Publicado: (2021)

Machine Learning for Predicting Heart Failure Progression in Hypertrophic Cardiomyopathy
por: Fahmy, Ahmed S., et al.
Publicado: (2021)

Significance and Determinants of Plasma Apelin in Patients With Obstructive Hypertrophic Cardiomyopathy
por: Yang, Chengzhi, et al.
Publicado: (2022)

Case report: Metastatic melanoma masquerading as apical hypertrophic cardiomyopathy
por: Ashraf, Muddasir, et al.
Publicado: (2022)

Advanced searching for hypertrophic cardiomyopathy heritability in real practice tomorrow
por: Chumakova, Olga S., et al.
Publicado: (2023)

Sex-Related Differences in Protein Expression in Sarcomere Mutation-Positive Hypertrophic Cardiomyopathy
por: Schuldt, Maike, et al.
Publicado: (2021)

Comparing the efficacy and safety of medications in adults with hypertrophic cardiomyopathy: a systematic review and network meta-analysis
por: Mi, Keying, et al.
Publicado: (2023)

Apical Ballooning and Cardiogenic Shock in Obstructive Hypertrophic Cardiomyopathy
por: Sherrid, Mark V., et al.
Publicado: (2018)

Ventricular Arrhythmia in Septal and Apical Hypertrophic Cardiomyopathy: The French-Canadian Experience
por: Steinberg, Christian, et al.
Publicado: (2020)

Thoracoscopic Trans-mitral Septal Myectomy for Hypertrophic Obstructive Cardiomyopathy in the Elderly
por: Wei, Peijian, et al.
Publicado: (2022)

Hypertrophic Obstructive Cardiomyopathy: Comparison of Outcomes After Myectomy or Alcohol Ablation
por: Meng, Xiangbin, et al.
Publicado: (2022)

Differences in microRNA-29 and Pro-fibrotic Gene Expression in Mouse and Human Hypertrophic Cardiomyopathy
por: Liu, Yamin, et al.
Publicado: (2019)

Radiomics-Based Classification of Left Ventricular Non-compaction, Hypertrophic Cardiomyopathy, and Dilated Cardiomyopathy in Cardiovascular Magnetic Resonance
por: Izquierdo, Cristian, et al.
Publicado: (2021)

Derivation and Validation of a Screening Model for Hypertrophic Cardiomyopathy Based on Electrocardiogram Features
por: Guo, Lanyan, et al.
Publicado: (2022)

Twenty-four hour variability of inverted T-waves in patients with apical hypertrophic cardiomyopathy
por: Ma, Fei, et al.
Publicado: (2022)

Ventricular arrhythmia and sudden cardiac death in hypertrophic cardiomyopathy: From bench to bedside
por: Shen, Hua, et al.
Publicado: (2022)

Tale of two hearts: a TNNT2 hypertrophic cardiomyopathy case report
por: Pham, Justin H., et al.
Publicado: (2023)

Body composition and mortality in a cohort study of Chinese patients with hypertrophic cardiomyopathy
por: Zhou, Ke, et al.
Publicado: (2023)

Temporal trends of hypertrophic cardiomyopathy in Denmark: a nationwide retrospective cohort study
por: Zörner, Christopher Ryan, et al.
Publicado: (2023)

Clinical significance of genetic variation in hypertrophic cardiomyopathy: comparison of computational tools to prioritize missense variants
por: Barbosa, Pedro, et al.
Publicado: (2022)

Syndrome of Reversible Cardiogenic Shock and Left Ventricular Ballooning in Obstructive Hypertrophic Cardiomyopathy
por: Sherrid, Mark V., et al.
Publicado: (2021)

COVID-19 INFECTION IN A PATIENT WITH HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY
por: AFRAZ PASHA, MOHAMMED, et al.
Publicado: (2021)

Deep Learning Analysis of Echocardiographic Images to Predict Positive Genotype in Patients With Hypertrophic Cardiomyopathy
por: Morita, Sae X., et al.
Publicado: (2021)

The Impact of Ischemia Assessed by Magnetic Resonance on Functional, Arrhythmic, and Imaging Features of Hypertrophic Cardiomyopathy
por: Aguiar Rosa, Sílvia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fp6u0tpviktudhab165m5kupvq